Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14).
Li
Jian-yong
JY
Wang
Li-xia
LX
Shen
Wen-yi
WY
Lu
Shi-feng
SF
Chen
Li-juan
LJ
Lu
Hua
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D003907:Dexamethasone / Q000008:administration & dosage; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D006811:Humerus / Q000473:pathology; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D011719:Pyrazines / Q000008:administration & dosage; D014178:Translocation, Genetic
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone